Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject
- PMID: 20096514
- DOI: 10.1016/j.forsciint.2009.12.038
Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject
Abstract
Methylphenidate (MPH) is a stimulant medication widely used for treating attention-deficit hyperactivity disorder (ADHD) in children and adolescents. Therapeutic monitoring for this drug is essentially lacking and alternative biological matrices, such as oral fluid and sweat, should be investigated for noninvasive assessment of short- and long-term history of drug use. We report the excretion profile of MHP and its metabolite ritalinic acid (RA) in oral fluid and sweat from a 12-year-old boy treated with the extended release drug formulation. Concentrations of MPH and RA in oral fluid, sweat and plasma were measured by liquid chromatography-mass spectrometry. Oral fluid-to-plasma ratio at each time interval was calculated at the start of the treatment and correlated with salivary pH. Excretion of MPH in sweat patches, collected up to 24h with PharmChek patches was also investigated. MPH and RA were both detected in oral fluid with a pharmacokinetic profile similar to that in plasma. Oral fluid peak concentrations of MPH ranged between 13.5 and 30.9 ng/mL at 3.0 h after drug intake. Oral fluid-to-plasma MPH ratio between 13.1 and 3.2 demonstrated an accumulation of the drug in oral fluid. Conversely, RA was found in oral fluid at peak concentration (23.4-62.9 ng/mL) equivalent to one-tenth of those found in plasma. Concentration profiles of MPH and RA in oral fluid were quite constant during the four weeks of drug administration. In sweat, MPH was detected for the first time at 5h after drug administration (range: 9.3-11.2 ng/patch) up to 24h (range: 29.8-38.7 ng/patch). RA was not detected in the sweat patches during the 24h time of collection. The results suggest that measurement of MPH in oral fluid can be used as a potential alternative to drug monitoring in plasma. Moreover, MPH measurement in sweat patches can be used for noninvasive monitoring of MPH consumption and misuse in situations where detection of recent abuse is of interest.
Copyright 2010. Published by Elsevier Ireland Ltd.
Similar articles
-
Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study.Ther Drug Monit. 2010 Aug;32(4):508-11. doi: 10.1097/FTD.0b013e3181e4e6f8. Ther Drug Monit. 2010. PMID: 20535053
-
Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices.J Pharm Biomed Anal. 2009 Feb 20;49(2):434-9. doi: 10.1016/j.jpba.2008.11.020. Epub 2008 Nov 27. J Pharm Biomed Anal. 2009. PMID: 19117711
-
In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.Biopharm Drug Dispos. 2004 Mar;25(2):91-8. doi: 10.1002/bdd.390. Biopharm Drug Dispos. 2004. PMID: 14872557 Clinical Trial.
-
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.Expert Rev Neurother. 2009 Aug;9(8):1121-31. doi: 10.1586/ern.09.65. Expert Rev Neurother. 2009. PMID: 19673602 Review.
-
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Clin Ther. 2008. PMID: 18555941 Review.
Cited by
-
Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.Clin Pharmacokinet. 2015 Nov;54(11):1151-60. doi: 10.1007/s40262-015-0269-z. Clin Pharmacokinet. 2015. PMID: 25910879
-
Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children.J Clin Pharmacol. 2018 Oct;58 Suppl 10(Suppl 10):S58-S72. doi: 10.1002/jcph.1053. J Clin Pharmacol. 2018. PMID: 30248192 Free PMC article. Review.
-
Adverse reactions of Methylphenidate in children with attention deficit-hyperactivity disorder: Report from a referral center.J Res Pharm Pract. 2014 Oct;3(4):130-6. doi: 10.4103/2279-042X.145389. J Res Pharm Pract. 2014. PMID: 25535621 Free PMC article.
-
Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy.Biosensors (Basel). 2023 Jul 12;13(7):726. doi: 10.3390/bios13070726. Biosensors (Basel). 2023. PMID: 37504123 Free PMC article. Review.
-
Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.J Pharm Sci. 2011 Jul;100(7):2966-78. doi: 10.1002/jps.22476. Epub 2011 Jan 14. J Pharm Sci. 2011. PMID: 21240977 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical